- Published at
- by gurufocus.com
mixed
mixed
News for Harpoon Therapeutics, Inc. (HARP)
- Published at
- by manilatimes.net
mixedmixed- Published at
- by investing.com
mixedmixedContext Therapeutics enhances board with new appointments By Investing.com
Context Therapeutics enhances board with new appointments- Published at
- by investing.com
mixedmixedBig Pharma Stocks: Who’s Leading the Race and Who’s Slipping?
Stocks Analysis by The Tokenist (Timothy Fries) covering: Eli Lilly and Company, Merck & Company Inc, Johnson & Johnson, Procter & Gamble Company. Read The Tokenist (Timothy Fries)'s latest article on Investing.com- Published at
- by globenewswire.com
mixedmixedZentalis Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Progress
$426.4M cash, cash equivalents and marketable securities as of June 30, 2024;Projected cash runway into mid-2026 SAN DIEGO, Aug. 09, 2024...- Published at
- by globenewswire.com
mixedmixedZentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, M.D., to Board of Directors
NEW YORK and SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company...- Published at
- by livemint.com
negativenegativeAmgen Drug Wins US Approval for Type of Advanced Lung Cancer
Amgen Inc. won US approval for a new drug to treat a particularly aggressive form of advanced lung cancer, providing a badly needed new option for patients when chemotherapy stops working.- Published at
- by investing.com
negativenegativeMerck raises 2024 profit forecast on strong cancer, HPV drugs sales By Reuters
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales- Published at
- by globenewswire.com
mixedmixedZymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting
VANCOUVER, British Columbia, April 08, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a...- Published at
- by asiaone.com
mixedmixedZymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting
Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting GlobeNewswire April 08, 2024 VANCOUVER, British Columbia, April 08, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of...- Published at
- by investing.com
mixedmixed- Published at
- by marketscreener.com
mixedmixedMerck Announces Fourth-Quarter and Full-Year 2023 Financial Results
Fourth-Quarter and Full-Year Sales Reflect Sustained Growth Across Oncology and Vaccines Fourth-Quarter Worldwide Sales Were $14.6 Billion, an Increase of 6% From Fourth Quarter 2022; Excluding...- Published at
- by globenewswire.com
positivepositive- Published at
- by globenewswire.com
mixedmixedSHAREHOLDER RIGHTS INVESTIGATION: Halper Sadeh LLC Investigates HARP, AMAM, AXNX, EAR
NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...- Published at
- by benzinga.com
mixedmixedWhy RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday’s Mid-Day Session - Ambrx Biopharma (NASDAQ:AMAM), Ampio Pharmaceuticals (AMEX:AMPE)
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.WWWVINCWVINCUVINCVEROUPWK.MXUPWKUPCSTTKSPRSILKPRAXOPK.TAOPK.MXOPKNKTXNEXINDMLFNDM.TONAKJNJHARPDJNJ3.BADJNJ2.BACYCCPCYCCCROXBSGMBOEI34.SABOEI.BRBOE.LBHGBCRX.MXBCRXBCO.DEBA.SNBA.MXBAAXNXAVDLARDXAMPEAMAM0VA3.L0KCS.LTREET77.DESNMPRVNCPRTAPACBMTCFSLY.MXFSLYF1SL34.SADVAXDADACMCBFLY-WTBFLYARBKFARB.L0Y3M.L0JTZ.L0IDA.L0A3P.LRGNX- Published at
- by benzinga.com
mixedmixed- Published at
- by benzinga.com
mixedmixedWhy Logitech International Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket - Argo Blockchain (NASDAQ:ARBK), Ascent Solar Technologies (NASDAQ:ASTI)
Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares surged 91.2% to $0.2180 in pre-market trading after falling 10% on Monday.- Published at
- by benzinga.com
mixedmixedWhy EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday’s Mid-Day Session - Abacus Life (NASDAQ:ABL), Aclarion (NASDAQ:ACON)
Gainers INVO Bioscience, Inc. (NASDAQ: INVO) jumped 375% to $2.57 as the company agreed to acquire NAYA Biosciences in an all-stock transaction.- Published at
- by benzinga.com
mixedmixedWhy Troika Media Group Shares Are Trading Lower By Over 20%; Here Are 20 Stocks Moving Premarket - Akumin (NASDAQ:AKU), Bit Brother (NASDAQ:BETS)
Gainers LumiraDx Limited (NASDAQ: LMDX) shares surged 151.7% to $0.2190 in pre-market trading after the company reported a strategic collaboration with AstraZeneca and Everton in the Community to set up England’s first community-based heart and lung screening hub.- Published at
- by globenewswire.com
mixedmixedHarpoon Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Abstracts for HPN217 and HPN328 accepted for presentations at the International Myeloma Society (IMS) Annual Meeting and the European Society for Medical...